2,7-dioxofagonene - Compound Card

2,7-dioxofagonene

Select a section from the left sidebar

2,7-dioxofagonene

Structure
Zoomed Structure
  • Family: Zygophyllaceae
  • Kingdom: Plantae
  • Class: Terpenoid
    • Subclass: Diterpene
Canonical Smiles OC[C@H]([C@@]1(C)CC[C@]2([C@H](C1)C(=O)C[C@]1([C@@H]2CC(=O)C=C1C)C)C)O
InChI InChI=1S/C20H30O4/c1-12-7-13(22)8-16-19(3)6-5-18(2,17(24)11-21)9-14(19)15(23)10-20(12,16)4/h7,14,16-17,21,24H,5-6,8-11H2,1-4H3/t14-,16-,17-,18+,19+,20-/m1/s1
InChIKey KVWZPTGHOOZLNP-VWJUVAHCSA-N
Formula C20H30O4
HBA 4
HBD 2
MW 334.46
Rotatable Bonds 2
TPSA 74.6
LogP 2.67
Number Rings 3
Number Aromatic Rings 0
Heavy Atom Count 24
Formal Charge 0
Fraction CSP3 0.8
Exact Mass 334.21
Number of Lipinski Rule Violations 0
# Species Family Kingdom NCBI Taxonomy ID
1 Fagonia glutinosa Zygophyllaceae Plantae 291461

Showing of synonyms

  • Abdel-Kader M, Omar A, et al. (1994). Erythroxan diterpenes from fagonia species. Phytochemistry,1994,36(6),1431-1433. [View]

No compound-protein relationship available.

Structure

SMILES: C1C(=O)C=CC(CC2=O)C1C(C23)CCCC3

Level: 0

Mol. Weight: 218.3 g/mol

No bioactivities available.

Absorption

Caco-2 (logPapp)
-4.51
Human Oral Bioavailability 20%
Bioavailable
Human Intestinal Absorption
Absorbed
Madin-Darby Canine Kidney
-4.46
Human Oral Bioavailability 50%
Bioavailable
P-Glycoprotein Inhibitor
Non-Inhibitor
P-Glycoprotein Substrate
Non-Substrate
Skin Permeability
-2.51

Distribution

Blood-Brain Barrier (CNS)
-
Blood-Brain Barrier
Penetrable
Fraction Unbound (Human)
0.83
Plasma Protein Binding
67.22
Steady State Volume of Distribution
-

Metabolism

Breast Cancer Resistance Protein
Non-Inhibitor
CYP 1A2 Inhibitor
Non-Inhibitor
CYP 1A2 Substrate
Substrate
CYP 2C19 Inhibitor
Non-Inhibitor
CYP 2C19 Substrate
Substrate
CYP 2C9 Inhibitor
Non-Inhibitor
CYP 2C9 Substrate
Non-Substrate
CYP 2D6 Inhibitor
Non-Inhibitor
CYP 2D6 Substrate
Non-Substrate
CYP 3A4 Inhibitor
Non-Inhibitor
CYP 3A4 Substrate
Substrate
OATP1B1
Non-Inhibitor
OATP1B3
Non-Inhibitor

Excretion

Clearance
12.28
Organic Cation Transporter 2
Inhibitor
Half-Life of Drug
-

Toxicity

AMES Mutagenesis
Toxic
Avian
Safe
Bee
Toxic
Bioconcentration Factor
-1.17
Biodegradation
Safe
Carcinogenesis
Toxic
Crustacean
Safe
Liver Injury I (DILI)
Safe
Eye Corrosion
Safe
Eye Irritation
Safe
Maximum Tolerated Dose
0.16
Liver Injury II
Toxic
hERG Blockers
Safe
Daphnia Maga
4.66
Micronucleos
Safe
NR-AhR
Safe
NR-AR
Toxic
NR-AR-LBD
Safe
NR-Aromatase
Safe
NR-ER
Safe
NR-ER-LBD
Safe
NR-GR
Toxic
NR-PPAR-gamma
Safe
NR-TR
Safe
T. Pyriformis
-0.84
Rat (Acute)
2.42
Rat (Chronic Oral)
1.87
Fathead Minnow
3.92
Respiratory Disease
Toxic
Skin Sensitisation
Safe
SR-ARE
Safe
SR-ATAD5
Safe
SR-HSE
Safe
SR-MMP
Safe
SR-p53
Safe

General Properties

Boiling Point
419.61
Hydration Free Energy
-8.2
Log(D) at pH=7.4
1.84
Log(P)
1.14
Log S
-2.9
Log(Vapor Pressure)
-8.0
Melting Point
191.04
pKa Acid
7.94
pKa Basic
3.7
Protein Name UniProt ID Entry Name Species #Pharmacophore Points Probability (0.7 ≤ Tversky Score ≤ 1.0)
Soluble acetylcholine receptor Q8WSF8 Q8WSF8_APLCA Aplysia californica 3 0.7609

Download SDF